39173065|t|Carvedilol suppresses ryanodine receptor-dependent Ca2+ bursts in human neurons bearing PSEN1 variants found in early onset Alzheimer's disease.
39173065|a|Seizures are increasingly being recognized as the hallmark of Alzheimer's disease (AD). Neuronal hyperactivity can be a consequence of neuronal damage caused by abnormal amyloid beta (Ass) depositions. However, it can also be a cell-autonomous phenomenon causing AD by Ass-independent mechanisms. Various studies using animal models have shown that Ca2+ is released from the endoplasmic reticulum (ER) via type 1 inositol triphosphate receptors (InsP3R1s) and ryanodine receptors (RyRs). To investigate which is the main pathophysiological mechanism in human neurons, we measured Ca2+ signaling in neural cells derived from three early-onset AD patients harboring Presenilin-1 variants (PSEN1 p.A246E, p.L286V, and p.M146L). Of these, it has been reported that PSEN1 p.A246E and p.L286V did not produce a significant amount of abnormal Ass. We found all PSEN1-mutant neurons, but not wild-type, caused abnormal Ca2+-bursts in a manner dependent on the calcium channel, Ryanodine Receptor 2 (RyR2). Indeed, carvedilol, an RyR2 inhibitor, and VK-II-86, an analog of carvedilol without the beta-blocking effects, sufficiently eliminated the abnormal Ca2+ bursts. In contrast, Dantrolene, an inhibitor of RyR1 and RyR3, and Xestospongin c, an IP3R inhibitor, did not attenuate the Ca2+-bursts. The Western blotting showed that RyR2 expression was not affected by PSEN1 p.A246E, suggesting that the variant may activate the RyR2. The RNA-Seq data revealed that ER-stress responsive genes were increased, and mitochondrial Ca2+-transporter genes were decreased in PSEN1A246E cells compared to the WT neurons. Thus, we propose that aberrant Ca2+ signaling is a key link between human pathogenic PSEN1 variants and cell-intrinsic hyperactivity prior to deposition of abnormal Ass, offering prospects for the development of targeted prevention strategies for at-risk individuals.
39173065	0	10	Carvedilol	Chemical	MESH:D000077261
39173065	51	55	Ca2+	Chemical	-
39173065	66	71	human	Species	9606
39173065	88	93	PSEN1	Gene	5663
39173065	124	143	Alzheimer's disease	Disease	MESH:D000544
39173065	145	153	Seizures	Disease	MESH:D012640
39173065	207	226	Alzheimer's disease	Disease	MESH:D000544
39173065	228	230	AD	Disease	MESH:D000544
39173065	233	255	Neuronal hyperactivity	Disease	MESH:D001289
39173065	280	295	neuronal damage	Disease	MESH:D009410
39173065	315	327	amyloid beta	Gene	351
39173065	329	332	Ass	Gene	445
39173065	408	410	AD	Disease	MESH:D000544
39173065	414	417	Ass	Gene	445
39173065	494	498	Ca2+	Chemical	-
39173065	698	703	human	Species	9606
39173065	725	729	Ca2+	Chemical	-
39173065	787	789	AD	Disease	MESH:D000544
39173065	790	798	patients	Species	9606
39173065	809	821	Presenilin-1	Gene	5663
39173065	832	837	PSEN1	Gene	5663
39173065	838	845	p.A246E	ProteinMutation	tmVar:p|SUB|A|246|E;HGVS:p.A246E;VariantGroup:1;CorrespondingGene:5663;RS#:63750526;CorrespondingSpecies:9606;CA#:225104
39173065	847	854	p.L286V	ProteinMutation	tmVar:p|SUB|L|286|V;HGVS:p.L286V;VariantGroup:0;CorrespondingGene:5663;RS#:63751235;CorrespondingSpecies:9606;CA#:225141
39173065	860	867	p.M146L	ProteinMutation	tmVar:p|SUB|M|146|L;HGVS:p.M146L;VariantGroup:2;CorrespondingGene:5663;RS#:63750306;CorrespondingSpecies:9606;CA#:225022
39173065	906	911	PSEN1	Gene	5663
39173065	912	919	p.A246E	ProteinMutation	tmVar:p|SUB|A|246|E;HGVS:p.A246E;VariantGroup:1;CorrespondingGene:5663;RS#:63750526;CorrespondingSpecies:9606;CA#:225104
39173065	924	931	p.L286V	ProteinMutation	tmVar:p|SUB|L|286|V;HGVS:p.L286V;VariantGroup:0;CorrespondingGene:5663;RS#:63751235;CorrespondingSpecies:9606;CA#:225141
39173065	981	984	Ass	Gene	445
39173065	999	1004	PSEN1	Gene	5663
39173065	1056	1060	Ca2+	Chemical	-
39173065	1097	1104	calcium	Chemical	MESH:D002118
39173065	1114	1134	Ryanodine Receptor 2	Gene	6262
39173065	1136	1140	RyR2	Gene	6262
39173065	1151	1161	carvedilol	Chemical	MESH:D000077261
39173065	1166	1170	RyR2	Gene	6262
39173065	1186	1194	VK-II-86	Chemical	-
39173065	1209	1219	carvedilol	Chemical	MESH:D000077261
39173065	1292	1296	Ca2+	Chemical	-
39173065	1318	1328	Dantrolene	Chemical	MESH:D003620
39173065	1346	1350	RyR1	Gene	6261
39173065	1355	1359	RyR3	Gene	6263
39173065	1384	1388	IP3R	Gene	3710
39173065	1422	1426	Ca2+	Chemical	-
39173065	1468	1472	RyR2	Gene	6262
39173065	1504	1509	PSEN1	Gene	5663
39173065	1510	1517	p.A246E	ProteinMutation	tmVar:p|SUB|A|246|E;HGVS:p.A246E;VariantGroup:1;CorrespondingGene:5663;RS#:63750526;CorrespondingSpecies:9606;CA#:225104
39173065	1564	1568	RyR2	Gene	6262
39173065	1779	1783	Ca2+	Chemical	-
39173065	1816	1821	human	Species	9606
39173065	1833	1838	PSEN1	Gene	5663
39173065	1913	1916	Ass	Gene	445
39173065	Positive_Correlation	MESH:D000544	RS#:63750526;HGVS:p.A246E;CorrespondingGene:5663
39173065	Positive_Correlation	MESH:D001289	351
39173065	Negative_Correlation	MESH:D003620	6263
39173065	Positive_Correlation	MESH:D000544	RS#:63751235;HGVS:p.L286V;CorrespondingGene:5663
39173065	Association	MESH:D002118	6262
39173065	Positive_Correlation	MESH:D000544	RS#:63750306;HGVS:p.M146L;CorrespondingGene:5663
39173065	Association	MESH:D000077261	MESH:D000544
39173065	Association	MESH:D000544	5663
39173065	Negative_Correlation	MESH:D003620	6261
39173065	Positive_Correlation	MESH:D001289	445
39173065	Negative_Correlation	MESH:D000077261	6262
39173065	Positive_Correlation	MESH:D009410	351
39173065	Association	MESH:D002118	5663
39173065	Association	5663	6262

